Edwards Lifesciences Corp. buy Royal Bank of Canada
Start price
26.10.23
/
50%
€60.38
Target price
26.10.24
€77.62
Performance (%)
4.84%
Price
30.08.24
€63.30
Summary
This prediction is currently active. With a performance of 4.84%, the BUY prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp. is trending in the right direction. This prediction currently runs until 26.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edwards Lifesciences Corp. | -0.047% | -0.047% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Royal Bank of Canada from $86.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€56.76
25.07.24
25.07.24
€78.23
25.07.25
25.07.25
11.52%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€83.96
15.04.24
15.04.24
€95.04
15.04.25
15.04.25
-24.61%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.68
07.02.24
07.02.24
€88.24
07.02.25
07.02.25
-21.54%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€67.68
12.01.24
12.01.24
€74.84
12.01.25
12.01.25
-6.47%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€71.40
17.08.23
17.08.23
€88.14
17.08.24
17.08.24
-12.17%
18.08.24
18.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€74.66
01.08.23
01.08.23
€87.48
01.08.24
01.08.24
-23.52%
02.08.24
02.08.24